Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119386752 | 11938675 | 2 | F | 2015 | 20160708 | 20160122 | 20160718 | EXP | CA-ROCHE-1525621 | ROCHE | 0.00 | F | Y | 66.28000 | KG | 20160718 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119386752 | 11938675 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 125276 | 252 | MG | SOLUTION FOR INFUSION | ||||||||
| 119386752 | 11938675 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 125276 | 544 | MG | SOLUTION FOR INFUSION | ||||||||
| 119386752 | 11938675 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 125276 | 600 | MG | SOLUTION FOR INFUSION | ||||||||
| 119386752 | 11938675 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 125276 | 520 | MG | SOLUTION FOR INFUSION | ||||||||
| 119386752 | 11938675 | 5 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 125276 | 600 | MG | SOLUTION FOR INFUSION | ||||||||
| 119386752 | 11938675 | 6 | SS | ACTEMRA | TOCILIZUMAB | 1 | Subcutaneous | U | 125472 | 162 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||||
| 119386752 | 11938675 | 7 | SS | ACTEMRA | TOCILIZUMAB | 1 | Subcutaneous | U | 125472 | 162 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||||
| 119386752 | 11938675 | 8 | C | MELOXICAM. | MELOXICAM | 1 | 0 | ||||||||||||
| 119386752 | 11938675 | 9 | C | RABEPRAZOLE | RABEPRAZOLE | 1 | 0 | ||||||||||||
| 119386752 | 11938675 | 10 | C | PAXIL (CANADA) | 2 | 0 | |||||||||||||
| 119386752 | 11938675 | 11 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 | ||||||||||||
| 119386752 | 11938675 | 12 | C | TUMS | CALCIUM CARBONATE | 1 | 0 | ||||||||||||
| 119386752 | 11938675 | 13 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | Oral | 0 | 8 | MG | QD | ||||||||
| 119386752 | 11938675 | 14 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | Oral | 0 | 6 | MG | QD | ||||||||
| 119386752 | 11938675 | 15 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | Oral | 0 | 2 | MG | QD | ||||||||
| 119386752 | 11938675 | 16 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | Oral | 0 | 8 | MG | QD | ||||||||
| 119386752 | 11938675 | 17 | C | LORAZEPAM. | LORAZEPAM | 1 | Oral | 1 PILL PRN | 0 | TABLET | |||||||||
| 119386752 | 11938675 | 18 | C | LORAZEPAM. | LORAZEPAM | 1 | 0 | ||||||||||||
| 119386752 | 11938675 | 19 | C | DICLECTIN | DOXYLAMINE SUCCINATEPYRIDOXINE HYDROCHLORIDE | 1 | Oral | 1 PILL PRN | 0 | ||||||||||
| 119386752 | 11938675 | 20 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 0 | 1 | MG | QD | ||||||||
| 119386752 | 11938675 | 21 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 1 PILL | 0 | QD | |||||||||
| 119386752 | 11938675 | 22 | C | RHOGAM | HUMAN RHO(D) IMMUNE GLOBULIN | 1 | Unknown | 1 SHOT/ DAY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119386752 | 11938675 | 1 | Rheumatoid arthritis |
| 119386752 | 11938675 | 6 | Rheumatoid arthritis |
| 119386752 | 11938675 | 13 | Pain |
| 119386752 | 11938675 | 17 | Anxiety |
| 119386752 | 11938675 | 18 | Depression |
| 119386752 | 11938675 | 19 | Nausea |
| 119386752 | 11938675 | 21 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119386752 | 11938675 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119386752 | 11938675 | Arthralgia | |
| 119386752 | 11938675 | Drug dose omission | |
| 119386752 | 11938675 | Maternal exposure during pregnancy | |
| 119386752 | 11938675 | Muscle spasms | |
| 119386752 | 11938675 | Nasopharyngitis | |
| 119386752 | 11938675 | Nausea | |
| 119386752 | 11938675 | Ovarian cyst | |
| 119386752 | 11938675 | Pain | |
| 119386752 | 11938675 | Urinary tract infection | |
| 119386752 | 11938675 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119386752 | 11938675 | 1 | 20130301 | 0 | ||
| 119386752 | 11938675 | 2 | 20130821 | 0 | ||
| 119386752 | 11938675 | 3 | 20130707 | 0 | ||
| 119386752 | 11938675 | 4 | 20141126 | 0 | ||
| 119386752 | 11938675 | 5 | 20150121 | 20150121 | 0 | |
| 119386752 | 11938675 | 6 | 20131214 | 20150903 | 0 | |
| 119386752 | 11938675 | 7 | 20150210 | 2016 | 0 | |
| 119386752 | 11938675 | 13 | 20141214 | 20150128 | 0 | |
| 119386752 | 11938675 | 14 | 20150129 | 20150131 | 0 | |
| 119386752 | 11938675 | 15 | 20150201 | 20150203 | 0 | |
| 119386752 | 11938675 | 16 | 20141214 | 20150316 | 0 | |
| 119386752 | 11938675 | 17 | 20141214 | 20150116 | 0 | |
| 119386752 | 11938675 | 19 | 20150116 | 0 | ||
| 119386752 | 11938675 | 20 | 20150116 | 0 | ||
| 119386752 | 11938675 | 21 | 20141214 | 20150316 | 0 | |
| 119386752 | 11938675 | 22 | 20150701 | 20150701 | 0 |